|
| |
Articles
1-100 out of 100 article(s)
| Title |
Author |
Type |
Date |
Words |
| Adopting the CEO model--why physician executives should not be required to practice medicine. |
Lazarus, Arthur |
|
Jul 1, 2008 |
1584 |
| Drug companies drain scientific brains from FDA, leaving less confident staff. |
|
|
Jun 17, 2008 |
495 |
| Inhaled-insulin maker feels pain of rival product's flop. |
Crowe, Deborah |
Company overview |
Apr 14, 2008 |
484 |
| Pharmacy board to weigh delays on drug tracking. |
Chambers, Heather |
|
Mar 24, 2008 |
499 |
| Schaefer Technologies, Inc. |
|
Company overview |
Mar 1, 2008 |
180 |
| Ruger Chemical Co., Inc. |
|
Company overview |
Mar 1, 2008 |
537 |
| Robinson Pharma Inc. |
|
Company overview |
Mar 1, 2008 |
433 |
| Lonza. |
|
Company overview |
Mar 1, 2008 |
444 |
| Indena. |
|
Company overview |
Mar 1, 2008 |
427 |
| Improve USA, Inc. |
|
Company overview |
Mar 1, 2008 |
227 |
| Gencor Pacific Inc. |
|
Company overview |
Mar 1, 2008 |
320 |
| Cognis[R] Nutrition & Health. |
|
Company overview |
Mar 1, 2008 |
407 |
| Cepham Inc. |
|
Company overview |
Mar 1, 2008 |
614 |
| Amerilab Technologies, Inc. |
|
Company overview |
Mar 1, 2008 |
401 |
| Puerto Rico's Gov. to visit drug firms Acevedo-Vila expected to ink pact with Biocom. |
Chambers, Heather |
|
Feb 18, 2008 |
813 |
| Legislation Proposed To Govern Use Of Deferred Prosecution Agreements, Selection Of Monitors, In Corporate Fraud Investigations. |
|
|
Feb 7, 2008 |
826 |
| RushNet expands. |
|
Brief article |
Feb 1, 2008 |
108 |
| Lost in the holiday shuffle: mergers, spin-offs, settlements. |
Sanders, Bob |
|
Jan 18, 2008 |
1299 |
| Pfizer expanding incubator concept to Bay Area, Boston: pharma giant to invest millions over five years. |
Chambers, Heather |
|
Jan 14, 2008 |
839 |
| Exeter. |
|
Brief article |
Dec 7, 2007 |
79 |
| Participants uninformed in some halted trials. |
|
|
Nov 5, 2007 |
670 |
| Skilled Nursing Pharmacy has signed a five-year lease for 5,062 square feet of industrial space located at 9920 Scripps Lake Drive, Suite 108, in Scripps Ranch. |
Schweizer, Andrew |
Brief article |
Oct 22, 2007 |
59 |
| Strategic audit: Tony Grundy explains why it's vital to give your strategy a health check. |
Grundy, Tony |
|
Sep 1, 2007 |
1382 |
| Clinton to lower cost of AIDS drugs. |
|
Brief article |
Jun 1, 2007 |
124 |
| More with less. |
Weeks, Katie |
Brief article |
Apr 16, 2007 |
166 |
| Human infectious diseases remain focus of vicars vaccine research: biotech boasts plentiful pipeline, two drugs in late phase trials. |
Weeks, Katie |
|
Apr 2, 2007 |
897 |
| Stella Labs. |
|
Company overview |
Mar 1, 2007 |
424 |
| Robinson Pharma. |
|
Company overview |
Mar 1, 2007 |
316 |
| Novum, LLC. |
|
Company overview |
Mar 1, 2007 |
266 |
| Lomapharm. |
|
Brief article |
Mar 1, 2007 |
263 |
| Indena. |
|
Company overview |
Mar 1, 2007 |
422 |
| Bioenergy Life Science, Inc. |
|
Company overview |
Mar 1, 2007 |
373 |
| Pharma expanding post-market surveillance, says PwC report. |
|
|
Feb 26, 2007 |
315 |
| How drug companies use bully tactics to get your business. |
|
|
Feb 1, 2007 |
1086 |
| Indena: a natural at botanical production. |
|
Company overview |
Jan 1, 2007 |
658 |
| Gencor Pacific Inc.: a traditional approach to lifestyle management. |
|
Company overview |
Dec 1, 2006 |
755 |
| Who are those guys? Using anonymized patient-level intelligence to size and characterize an undiagnosed population: anonymized patient-level intelligence can be used to provide more accurate insights into the prediabetic population. |
Carroll, Jim; Tirrell, Taryn |
|
Dec 1, 2006 |
950 |
| Inovio Biomedical Corp. bouncing back from shaky past, facing critical year: company raises $15.5m in sale of stock, gains $1.1m grant from U.S. Department of Defense. |
Weeks, Katie |
|
Nov 6, 2006 |
719 |
| Developing end-of-lifecycle strategies. |
Naigamwalla, Darius |
|
Nov 1, 2006 |
575 |
| Pharmaceutical representatives can deliver the brand promise: the sales representative plays a critical role in the marketing and branding processes. To do this, pharmaceutical reps in the field must constantly be in tune with the purpose of the companies they represent. |
Barlow, Janelle; Wardlaw, Jim |
|
Nov 1, 2006 |
2023 |
| Who really "Moves the Needle?" How to focus resources on the most important payer accounts. |
Lanzone, Tony |
|
Oct 1, 2006 |
1745 |
| Divide and conquer: novel patient-segmentation approach leads to new opportunities: anonymized patient-level data can be used to segment patients according to clinical factors, therapy usage, and demographics, allowing pharmaceutical companies to reach the right physicians and patients with the right messages. |
Carroll, Jim; Tirrell, Taryn |
|
Oct 1, 2006 |
1149 |
| Are You Making The Most Of The Explosion In Proprietary Device Technology? |
|
Brief article |
Sep 13, 2006 |
240 |
| Global Pharmatech, Inc. |
|
Brief article |
Sep 1, 2006 |
87 |
| The Benefits of Patents for Nutraceuticals. |
|
|
Aug 30, 2006 |
1615 |
| Cervical cancer R&D continues locally despite new vaccine: life sciences firms seek their share of $650 million market. |
Weeks, Katie |
|
Aug 7, 2006 |
990 |
| NIH scientist netted $285,000 by improperly sharing human tissue samples with Pfizer-House report. |
|
|
Jun 30, 2006 |
572 |
| Companies to watch: the fab five. |
Wright, Rebecca |
Editorial |
Jun 1, 2006 |
4632 |
| Major firms agree to disclose political gifts. |
Heffes, Ellen M. |
Brief article |
Mar 1, 2006 |
268 |
| Indena. |
|
Company overview |
Mar 1, 2006 |
462 |
| Anabolic Laboratories, Inc. |
|
Company overview |
Mar 1, 2006 |
327 |
| S.D. biotech, Kansas firm part ways. |
Weeks, Katie |
|
Feb 13, 2006 |
338 |
| Biotech success could lead to CytRx payoff, but there's risk. |
Crowe, Deborah |
Company Profile |
Feb 13, 2006 |
818 |
| Campaign promotes discount drug program. |
Weeks, Katie |
|
Jan 30, 2006 |
613 |
| S.D. biotech's shareholders question firm's candor on drug. |
Weeks, Katie |
|
Nov 21, 2005 |
1142 |
| UCSD considers altering clinical trial procedures: change could affect how fast some drugs get on the market. |
Weeks, Katie |
|
Nov 14, 2005 |
1049 |
| Amylin's drug Byetta misses mark. |
Weeks, Katie |
Brief Article |
Nov 7, 2005 |
323 |
| Welcoming workplaces: in 2005 a record number of Fortune 500 companies are offering protections to gay and lesbian workers and their spouses. Here are 10 shining examples of the best employers. |
Kuhr, Fred |
|
Oct 11, 2005 |
2754 |
| Wyeth's comeback kid: Robert Essner guides the pharma giant back from the fen-phen brink. |
Hawthorne, Fran |
|
Oct 1, 2005 |
2439 |
| Nothing to sneeze at: local firm looks to create stir in the competitive allergy market. |
Weeks, Katie |
Company Profile |
Aug 29, 2005 |
1151 |
| Avanir Pharmaceuticals. |
|
|
Jul 18, 2005 |
426 |
| Training is like preparing for a major business event. |
Webb, Marion |
|
Jul 4, 2005 |
711 |
| Parallel Trade in the Pharma Sector: Where Now for Stock Management? |
|
|
Jun 15, 2005 |
3489 |
| Perlegen Sciences expanded its efforts to genotype SNPs as part of the International HapMap Project from 600 million to over one billion. |
|
Brief Article |
May 31, 2005 |
29 |
| Gerald Yakatan looks at life after Avanir: venture funding an option for longtime local exec. |
Webb, Marion |
|
May 23, 2005 |
732 |
| Weekly profile. |
|
Brief Article |
Apr 25, 2005 |
209 |
| Big pharma R&D operations make changes. |
|
|
Apr 15, 2005 |
1259 |
| Amylin Pharmaceuticals. |
|
Company Profile |
Apr 11, 2005 |
434 |
| Auditors raise concerns about two firms. |
Allen, Mike |
|
Apr 11, 2005 |
644 |
| Ruger Chemical Co., Inc. |
|
Company Profile |
Mar 1, 2005 |
381 |
| Pharmachem Laboratories: Pharmachem celebrates 25th anniversary. |
|
Company Profile |
Mar 1, 2005 |
577 |
| Indena. |
|
Company Profile |
Mar 1, 2005 |
457 |
| Chr. Hansen, Inc. |
|
Company Profile |
Mar 1, 2005 |
347 |
| Cyanotech Corporation: pioneers in natural products sourced from microalgae. |
|
Company Profile |
Mar 1, 2005 |
590 |
| Orafti Active Food Ingredients: growing and expanding. |
|
Company Profile |
Mar 1, 2005 |
683 |
| ORPHAN MEDICAL EXPECTS 2005 REVENUE TO EXCEED $35 MILLION. |
|
|
Mar 1, 2005 |
648 |
| Book reviews. |
|
Brief Article |
Jan 1, 2005 |
176 |
| Why you can't afford your medications: and what you can do about it. |
|
|
Jan 1, 2005 |
1270 |
| Triad sells program to Novartis. |
Webb, Marion |
Brief Article |
Dec 13, 2004 |
152 |
| Major drug makers invest in promising startups: biotech forms S.D.-based capital fund. |
Webb, Marion |
|
Nov 22, 2004 |
818 |
| Phenomenome Discoveries Inc. breaks new ground. |
|
|
Nov 1, 2004 |
394 |
| Wyeth selected ID Business Solutions' ActivityBase data management software. |
|
Brief Article |
Oct 31, 2004 |
19 |
| Operating margins rise and SG&A spending increases. |
|
|
Sep 30, 2004 |
872 |
| Adding information. |
Webb, Marion |
Brief Article |
Sep 27, 2004 |
103 |
| Pharmaceutical labeling: driven mainly by brand protection concerns and regulations, pharmaceutical labels are becoming ever more sophisticated. |
Genuario, Leah |
|
Sep 1, 2004 |
2303 |
| Avera raises $48 million. |
Webb, Marion |
Brief Article |
Aug 16, 2004 |
140 |
| Pharmaceutical company heads North from Florida. |
|
Brief Article |
Aug 4, 2004 |
332 |
| Mayer, Brown, Rowe & Maw LLP Advises On XTLbio Fundraising. |
|
|
Aug 4, 2004 |
309 |
| Women First HealthCare files plan outlining repayment of creditors. |
Webb, Marion |
Brief Article |
Jul 26, 2004 |
253 |
| Solstice looks for shot in competitive Botox market: S.D. company is pushing Myobloc as a reasonable alternative. |
Webb, Marion |
|
Jul 19, 2004 |
954 |
| Case study: Metagenics. |
Clough, Tom |
|
Jul 1, 2004 |
819 |
| Roche deployed the integrated solution of Cellomics Store. |
|
Brief Article |
Jun 30, 2004 |
33 |
| AstraZeneca R&D Montreal awarded PerkinElmer an expanded contract under which it will use PerkinElmer's High Throughput Screening (HTS) assay technologies and functional HTS assays to test compounds. |
|
Brief Article |
Jun 30, 2004 |
44 |
| UK-based KuDOS Pharmaceuticals implemented Scientific Software. |
|
Brief Article |
Jun 15, 2004 |
11 |
| AstraZeneca expanded the deployment of SciTegic's Pipeline Pilot. |
|
Brief Article |
Jun 15, 2004 |
18 |
| Medicinal purpose: a firm that's enjoying a purple patch could be forgiven for thinking 'if it ain't broke, don't fix it', but this attitude is unlikely to prolong its success. Jim Heaney describes how his company, Norgine, reacted when it realised that, although its organisational model had been getting good results, it would be unable to sustain them in future. |
Heaney, Jim |
|
Jun 1, 2004 |
1153 |
| Indiana's technology targets: growing life sciences, IT, advanced manufacturing and logistics. |
|
|
May 1, 2004 |
2334 |
| PRODUCT FOCUS- PHARMACEUTICALS IN FINLAND. |
|
|
May 1, 2004 |
373 |
| Freshly washed: drug dealers, corporate swindlers cash in profits as money laundering continues to damage national image. |
Messenger, Rawdon |
|
May 1, 2004 |
1825 |
| Boxin Bio-pharmaceutical project in Qingdao. |
|
Brief Article |
Apr 16, 2004 |
102 |
|
